CLINICAL ROLE -
Unique Subset of Cells Team Up to Drive Rheumatoid Arthritis
Study opens doors for more precise RA treatments.
Read More
Aspirin-Lipid Drug Combination May Prevent Colorectal Cancer
Aspiring-PC/PL2200 reduced the amount of platelets that could be used by cancer cells to form blood vessels and spread.
High Presence of Sense of Smell Dysfunction Found in Patients with Multiple Sclerosis
Roughly half of MS patients had hyposmia at the beginning of the study.
Patients with Multiple Sclerosis Largely Support Medical Marijuana
95% of survey respondents support medical marijuana treatment for multiple sclerosis.
Lung Cancer Screening Program Poses a Challenge for Veterans Health Administration
Lung cancer demonstration project examines the feasibility of a screening program for veterans.
Xarelto Study Stopped Early Due to Positive Results
Xarelto found to prevent major adverse cardiac events, such as cardiovascular death, myocardial infarction, and stroke.
Ketamine Observed to Prevent PTSD
Prophylactic ketamine use may be able to prevent post-traumatic stress disorder among military personnel.
Chemotherapy, Twice-Daily Radiotherapy Combination Improves Head and Neck Cancer Survival
Combination treatment reduces head and neck cancer deaths by 20%.
HIV Drugs Could Cause Neurodegeneration
Treatment with protease inhibitors could result in HIV-associated neurocognitive diseases.
FDA Recalls Infusion Device
The FDA issued a recall of the Alaris Syringe Pump for a potentially faulty sensor.
Declining Hepatitis C Drug Costs Highlights Specialty Pharmacy Week in Review
Top articles of the week on Specialty Pharmacy Times.
Trending News Today: Efficacy of Newly-Approved Cancer Drugs in Question
Top news of the day from across the health care landscape.
Link Between Diabetes and Osteoarthritis
Obesity blamed for the tendency of diabetes patients to develop osteoarthritis.
Trending News Today: Oncology Drugs Approved Despite Lack of Proven Success
Top news of the day from across the healthcare landscape.
Ibuprofen Lysine Injection Recalled Due to Particulate Matter
FDA officials announced that Exela Pharma Sciences has voluntarily issued a nationwide recall of its ibuprofen lysine injection 20 mg/2 mL (10 mg/mL) vials.
Look and Look Again -- Getting to Know the Community Pharmacy Foundation
Although its organizational infrastructure is virtual, the Community Pharmacy Foundation (CPF) is ‘anything but’ and is quite quantifiable and impactful in its vision, mission, and deliverables.
FDA Approves Emflaza for Duchenne Muscular Dystrophy
Emflaza treats patients 5 years and older with DMD.
FDA Approves First Corticosteroid for Duchenne Muscular Dystrophy
Emflaza approved to treat patients with Duchenne muscular dystrophy.
NCPA Responds to PBM Efforts to Limit Potential Reforms
ASHP Names Chhay as 2017-2018 Executive Fellow
ASHP has selected Sophia R. Chhay as its 2017-2018 Executive Fellow in Association Leadership and Management.
FDA Approves Corticosteroid Treatment for Duchenne Muscular Dystrophy
FDA officials today announced the approval of Emflaza (deflazacort) tablets and oral suspension for the treatment of Duchenne muscular dystrophy (DMD).
Tackling CRISPRs Biggest Challenge Through Novel Delivery System
Gene-editing tool shows promise treating genetic diseases.
Closed-System Transfer Devices, USP , and the NIOSH Protocol
According to the National Institute for Occupational Safety and Health (NIOSH), an estimated 8 million health care workers in the United States are exposed to hazardous drugs (HDs) each year.
Pharmacy Technicians Face Charges for VA Hospital Prescription Drug Diversion Scheme
Three Veterans Affairs pharmacy employees are facing charges related to a conspiracy to steal and distribute prescription pills.
Dietary Supplement Distributor Reprimanded for Selling DMAA-Containing Products
Regeneca Worldwide, a California dietary supplement distributor, has been ordered to stop selling their products, FDA officials announced today.
Gilead Versus GlaxoSmithKline in the Battle for an HIV Cure
Manufacturers will present clinical trial results at the upcoming HIV medical meeting.
AbbVie's Pan-Genotypic Regimen for Hepatitis C Virus Shows Promise
Glecaprevir/pribrentasvir well-tolerated in patients with HCV genotype 1.
Medicare Advantage Plans May Be Overpaid Billions Over the Next Decade
Coding intensity may lead to $200 billion in unnecessary spending from Medicare Advantage plans by 2026.
FDA Approves Hyperparathyroidism Drug
Parsabiv is the first hyperparathyroidism drug to be approved in more than 10 years.
Unexpected Disease Activity Observed From Multiple Sclerosis Drug Swap
A change from fingolimod to alemtuzumab caused significant disease activity in patients with MS.